SELLAS Life Sciences
SLS
#4150
Rank
NZ$5.09 B
Marketcap
NZ$24.97
Share price
-8.08%
Change (1 day)
816.42%
Change (1 year)

Earnings for SELLAS Life Sciences (SLS)

Earnings in 2026 (TTM): -NZ$61.28 Million

According to SELLAS Life Sciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$51.69 Million, an increase over its 2024 earnings that were of -NZ$57.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SELLAS Life Sciences from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$61.28 Million18.56%
2025 -NZ$51.69 Million-10.28%
2024 -NZ$57.61 Million-16.78%
2023 -NZ$69.23 Million-9.73%
2022 -NZ$76.69 Million65.85%
2021 -NZ$46.24 Million48.95%
2020 -NZ$31.05 Million-1.31%
2019 -NZ$31.46 Million-44.65%
2018 -NZ$56.84 Million45.99%
2017 -NZ$38.93 Million-33.17%
2016 -NZ$58.26 Million-6.87%
2015 -NZ$62.56 Million-30.98%
2014 -NZ$90.64 Million46.52%
2013 -NZ$61.86 Million
2011 -NZ$30.71 Million
2008 -NZ$26.61 Million27.51%
2007 -NZ$20.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 343.33%๐Ÿ‡บ๐Ÿ‡ธ USA